Research Corporation Technologies Partners with Isogenica Limited for Large Scale Screening of a New Antibody-Derived Scaffold Platform

Published: Jul 11, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Research Corporation Technologies, Inc. (RCT), of Tucson, has partnered with Isogenica, of Cambridge, U.K., to access Isogenica’s CIS display platform for the screening of proprietary libraries of a new antigen-binding protein scaffold.

Back to news